Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Neuro-Oncology Advances|September 22, 2021
Low tumor cell content predicts favorable prognosis in germinoma patientsHirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Neuro-Oncology|February 9, 2022
Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterpartsHirokazu Takami, Asmaa Elzawahry, Yasin Mamatjan, et al.
Acta Neuropathologica Communications|July 26, 2024
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Acta Neuropathologica|January 13, 2017
Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomasShintaro Fukushima, Satoshi Yamashita, Hisato Kobayashi, et al.
Acta Neuropathologica|March 10, 2016
Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapyKoichi Ichimura, Shintaro Fukushima, Yasushi Totoki, et al.
Neuro-Oncology|August 21, 2020
So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?Masayuki Kanamori, Hirokazu Takami, Shigeru Yamaguchi, et al.
Neuro-Oncology Advances|December 11, 2024
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort studyMasayuki Kanamori, Shunsuke Tsuzuki, Ichiyo Shibahara, et al.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Acta Neuropathologica Communications|November 24, 2020
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutationsHideyuki Arita, Yuko Matsushita, Ryunosuke Machida, et al.
Acta Neuropathologica Communications|December 6, 2018
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumorsKohei Fukuoka, Yonehiro Kanemura, Tomoko Shofuda, et al.
Pageof 10